Abstract
Coagulopathy in acute promyelocytic leukemia (APL) is a very complex disorder and is believed to result from interplay of various factors. Usually patients present with bleeding tendencies which can be life threatening. However, a few present with thromboses. Here, we report a young male with APL who presented with ischemic stroke in young.
References
Warrell RP Jr, de The H, Wang ZY et al (1993) Acute promyelocytic leukemia. N Eng J Med 329:177–189
Barbui T, Finazzi G, Falanga A (1998) The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia. Blood 91:3093–3102
Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA (1999) Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340:994–1004
Falanga A, Barbui T (2001) Coagulopathy of acute promyelocytic leukemia. Acta Haematol 106:43–51
Runde V, Aul C, Heyll A et al (1992) All-trans-retinoic acid: not only a differentiating agent, but also an inducer of thromboembolic events in patients with M3 leukemia. Blood 79:534–535
Montesinos P, de la Serna J, Vellenga E et al. (2006) Incidence and risk factors for thrombosis in patients with acute promyelocytic leukemia. Experience of PETHEMA LPA 96 and LPA 99 protocols. Blood (ASH annual meeting abstracts) 108:1503
Breccia M, Avvisati G, Latagliat R et al (2007) Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia 21:79–83
Lou YJ, Mai WY, Jin J (2006) Simultaneous presentation of acute myocardial infarction and acute promyelocytic leukemia. Ann Hematol 85:409–410
Quadir TA, Dhabhar BN, Dhar AK et al (1993) Acute promyelocytic leukemia with ischemic events. J Assoc Physicians India 41:300–302
Bandyopadhyay S, Bandyopadhyay D (2010) Acute Budd-Chiari syndrome as an initial presentation of acute promyelocytic leukemia. J Cancer Res Ther 6:567–569
Escudier SM, Kantarjian HM, Estey EH (1996) Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans-retinoic acid. Leuk Lymphoma 20:435–439
Pogliani EM, Rossini F, Casaroli, Maffe P, Corneo G (1997) Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy. Acta Haematol 97:228–230
Hashimoto S, Koike T, Tatewaki W et al (1994) Fatal thromboembolism in acute promyelocytic leukemia during all-trans-retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Leukemia 8:1113–1115
Brown JE, Olujohungbe A, Chang J et al (2000) All-trans-retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukemia. Br J Haematol 110:1010–1012
Colovic M, Miljic P, Colovic N et al (2001) Reversible portal vein thrombosis complicating induction therapy of acute promyelolocytic leukemia. Thromb Res 101:101–103
Forjaz De Lacerda J, Alves Do Carmo J et al (1993) Multiple thrombosis in acute promyelocytic leukemia after tretinoin. Lancet 342:114–115
Assouline D, Negrier C, Coquard I et al (1995) Successful systemic thrombolysis of hepatic vein thrombosis in a patient with promyelocytic leukemia treated with all-trans-retinoic acid. Am J Haematol 48:291–292
Torromeo C, Latagliata R, Avvisati GF (1999) Coronaric thrombotic events in acute promyelocytic leukemia during all-trans-retinoic acid treatment: a role for adhesion molecules overexpression? Leukemia 13:312–313
Torromeo C, Latagliata R, Avvisati G et al (2001) Intraventricular thrombosis during all-trans-retinoic acid treatment in acute promyelocytic leukemia. Leukemia 15:1311–1313
Goldschmidt N, Gural A, Yehuda DB (2003) Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia. Leuk Lymphoma 44:1433–1437
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapoor, R., Pati, H.P., Gupta, S.K. et al. Acute Promyelocytic Leukemia Presenting as Ischemic Stroke in Young. Indian J Hematol Blood Transfus 29, 93–95 (2013). https://doi.org/10.1007/s12288-012-0145-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-012-0145-z